Risk factors
West Pharmaceutical Services (WST) risk factors
Item 1A of every West Pharmaceutical Services Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors32 risks3 new1 dropped5 reworded
The company added specific operational risks covering customer concentration, internal controls, and asset divestitures like the AbbVie SmartDose deal.
Filed Feb 17, 2026 - FY2024 10-K risk factors30 risks
International operations generate 57.5 percent of net sales, exposing the company to global economic and currency risks. Regulatory approvals from the FDA and global bodies govern core product commercialization and compliance. Sole-source raw material availability and manufacturing concentration in specific plants threaten operational continuity.
Filed Feb 18, 2025